ST. LOUIS, MO –- Certara®, the leading global technology-enabled drug development and drug safety consultancy, announced today that its Muse molecular design workflow for the identification and optimization of lead drug candidates now has virtual synthetic chemistry capabilities. Known as Muse® Invent™, this new product will enable researchers to create drug candidates with novel structures, […]
LA JOLLA, CA — Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today announced it has signed an agreement with Celgene Cellular Therapeutics (CCT) to license, develop, and co-promote Celgene’s proprietary placental cell population, PSC-100. HLI has the option to […]
CAMBRIDGE, UK — Optibrium™, a developer of software for drug discovery, today announced the launch of Sentira™, a new desktop application that provides dynamic data visualisation and analysis of compound data. Applicable across all fields of chemistry, Sentira enables users to quickly find patterns in compound data, visualise structure-activity relationships (SAR) and elegantly present and […]
Denville, NJ — Diagenode, Inc., a leading global provider of complete solutions for epigenetics research, recently launched the industry’s first monoclonal antibody targeting CRISPR/Cas9. The antibody has been extensively validated for a number of applications including western blotting, immunofluorescence to determine protein localization, and immunoprecipitation applications such as chromatin immunoprecipitation. The CRISPR/Cas system has been […]
ReproCELL Expects Synergy and Business Benefits through the Acquisitions of Reinnervate and BioServe
ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world’s first human iPS cell products in 2009 and with the world’s most advanced research and technology. Through the acquisitions of Reinnervate Limited […]
Moorestown, NJ — IonField Systems, the pioneer in plasma cleaning technology for life science applications, is pleased to announce the award of a Phase II Small Business Innovation Research (SBIR) grant totaling $1,000,000 for the development of an automated system to clean microplates with cold plasma technology. This project has been funded in whole or […]
SYDNEY & MOUNTAIN VIEW, Calif. & LA JOLLA, Calif.– The Garvan Institute of Medical Research, DNAnexus, and AllSeq, today announced that they are sponsoring free access to the world’s first publicly available datasets generated using the Illumina HiSeq X Ten DNA sequencing platform. The goal for this project is to provide researchers with sample data […]
Manassas, VA — ATCC, the premier global biological materials resource and standards organization, announced today that it has received ISO 13485:2003 certification for the development, manufacture, and distribution of standards, controls, reagents and in vitro diagnostic test kits. Every day researchers in life science, medical diagnostics, applied sciences, and clinical drug development leverage ATCC’s expansive […]
SAN DIEGO — Organovo Holdings, Inc. (NYSE MKT: ONVO) (“Organovo”), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today that Gregory T. Lucier has been appointed as a corporate advisor. In the role, Mr. Lucier will advise Chief Executive Officer Keith Murphy and the executive management team on various corporate issues. […]
RESEARCH TRIANGLE PARK, N.C.– Triangle Research Labs, LLC and Biopredic International have completed an agreement for TRL to distribute the No-Spin HepaRG™ cells in North America. The No-Spin HepaRG™ represent an important improvement over the original cryopreserved HepaRG™ cells introduced three years ago for ADMET analyses. The HepaRG™ are renewable and reproducible hepatic cells derived […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
